[HTML][HTML] Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell …
A Amin, AZ Dudek, TF Logan, RS Lance… - … for immunotherapy of …, 2015 - Springer
Background AGS-003 is an autologous immunotherapy prepared from fully matured and
optimized monocyte-derived dendritic cells, which are co-electroporated with amplified …
optimized monocyte-derived dendritic cells, which are co-electroporated with amplified …